Sol_75N95024R00086_Amd_0001.pdf

PDF 82 KB Posted

Attached to
Request for Proposals - Phase I Clinical Trials Federal contract opportunity
Solicitation number
75N95024R00086
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

This document is an amendment to a solicitation for a Request for Proposals (RFP) for Phase I Clinical Trials for the Development of Small Molecule and Biologics Therapeutics. The solicitation number is 75N95024R00086 and the amendment is administrative in nature, correcting details related to the period of performance which is April 1, 2025 to March 31, 2035. The solicitation is being issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse. The amendment provides instructions for offerors to acknowledge receipt of the amendment prior to the specified deadline in order to be considered.

View the file

Other files for this federal contract opportunity

Other files attached to Request for Proposals - Phase I Clinical Trials, newest first.
File Type Posted
Sol_75N95024R00086_Amd_0003.pdf PDF
RFP_75N95024R00086_Amnd_0003_0003.pdf PDF
Sol_75N95024R00086_Amd_0002.pdf PDF
RFP_75N95024R00086_Amnd_0002_0002.pdf PDF
A11_-_Additional_Technical_Proposal_Instructions.pdf PDF
A19_-_NIH(RC)-1_-_Invoice_Financing_Request_Instructions.pdf PDF
A1_-_RFP_Cover_Letter_081924_signed.pdf PDF
A16_-_Wage_Determination.pdf PDF
A4_-_Proposal_Summary_and_Data_Record__NIH-2043.pdf PDF
A13_-_Technical_Proposal_Cost_Summary.pdf PDF
A5_-_Offeror_s_Points_of_Contact.pdf PDF
A9_-_Sample_TORFP_2_SOW_-_SAD_Study_080624.pdf PDF
A18_-_DEC_Acknowledgment.pdf PDF
Sol_75N95024R00086.pdf PDF
A15_-_SBCX_Industry_Subcontracting_Guide.pdf PDF
A3_-_Proposal_Intent_Response_Form.pdf PDF
A22_-_PHS_Human_Subjects_and_Clinical_Trials_Information_Form-H.pdf PDF
A7_-_IDIQ_Contract_Statement_of_Work__080724.pdf PDF
A10_-_Sample_TORFP_3_SOW_-_SADMAD_Study_080624.pdf PDF
A12_-_Summary_of_Related_Activities.pdf PDF
A20_-_NIDA_Supplemental_Billing_Instructions.pdf PDF
A23_-_Protection_of_Human_Subjects_Assurance_Identification.pdf PDF
A14_-_Breakdown_of_Proposed_Estimated_Costs.xlsx XLSX spreadsheet
A2_-_Packaging_and_Delivery_of_Proposals_for_Use_with_the_NIH_eCPS_website.pdf PDF
A8_-_Sample_TORFP_1_SOW_-_Kickoff_Meeting_PMP.pdf PDF
A24_-_Public_Health_Surveillance_Exclusion_Request.pdf PDF
A17_-_Disclosure_of_Lobbying_Activities__OMB_Form_SF-LLL.pdf PDF
A6_-_Section_K_-_Representations__Certifications__and_Other_Statements_of_Offerors_May_2024.docx DOCX document
A21_-_NIH(RC)-2_-_Fixed-Price_Invoice_Instructions.pdf PDF
Show all 29

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

(x)

75N95024R00086 x x copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE

RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR

OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

x

NINDS

Bethesda, MD 20892-7511 Disorders and Stroke National Institute of Neurological National Institutes of Health

NIDA-EXEC

Bethesda, MD 20892-7511 National Institute on Drug Abuse National Institutes of Health

08/19/20240001

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

12. ACCOUNTING AND APPROPRIATION DATA (If required) is not extended.is extended, Items 8 and 15, and returning

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

FACILITY CODE CODE

10B. DATED (SEE ITEM 13)

10A. MODIFICATION OF CONTRACT/ORDER NO.

9B. DATED (SEE ITEM 11)

9A. AMENDMENT OF SOLICITATION NO.

CODE

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

7. ADMINISTERED BY (If other than Item 6)CODE 6. ISSUED BY

PAGE OF PAGES

4. REQUISITION/PURCHASE REQ. NO.3. EFFECTIVE DATE2. AMENDMENT/MODIFICATION NO. 5. PROJECT NO. (If applicable)

1. CONTRACT ID CODE

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

08/19/2024

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority) appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

E. IMPORTANT: Contractor is not is required to sign this document and return __________________ copies to the issuing office.

ORDER NO. IN ITEM 10A.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Amendment 001: Administrative Correction

Phase I Clinical Trials for Development of Small Molecule and Biologics Therapeutics

Please refer to Attachment 1: Cover Letter

Period of Performance: 04/01/2025 to 03/31/2035

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)15A. NAME AND TITLE OF SIGNER (Type or print)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA 15B. CONTRACTOR/OFFEROR 16C. DATE SIGNED

(Signature of person authorized to sign) (Signature of Contracting Officer)

RIEKA N. PLUGGE

STANDARD FORM 30 (REV. 11/2016)

Prescribed by GSA FAR (48 CFR) 53.243

Previous edition unusable

Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect .

File details come from the government source that posted it. Updated .